Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Prepaid Assets (2023 - 2025)

Historic Prepaid Assets for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $5.8 million.

  • Zenas BioPharma's Prepaid Assets fell 1749.53% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 1749.53%. This contributed to the annual value of $5.1 million for FY2024, which is 7193.76% up from last year.
  • Per Zenas BioPharma's latest filing, its Prepaid Assets stood at $5.8 million for Q3 2025, which was down 1749.53% from $5.3 million recorded in Q2 2025.
  • Over the past 5 years, Zenas BioPharma's Prepaid Assets peaked at $7.0 million during Q3 2024, and registered a low of $2.9 million during Q4 2023.
  • In the last 3 years, Zenas BioPharma's Prepaid Assets had a median value of $5.4 million in 2025 and averaged $5.3 million.
  • In the last 5 years, Zenas BioPharma's Prepaid Assets surged by 7193.76% in 2024 and then tumbled by 1749.53% in 2025.
  • Over the past 3 years, Zenas BioPharma's Prepaid Assets (Quarter) stood at $2.9 million in 2023, then surged by 71.94% to $5.1 million in 2024, then grew by 13.64% to $5.8 million in 2025.
  • Its last three reported values are $5.8 million in Q3 2025, $5.3 million for Q2 2025, and $5.4 million during Q1 2025.